Microsoft is building on its momentum in generative AI to move deeper into healthcare.
The tech giant found a major entry point into healthcare workflows when it acquired Nuance for $19.7B in 2022. It followed up on this by expanding its existing relationship with leading EHR vendor Epic to introduce generative AI across clinical workflows, with the aim of improving provider efficiency and mitigating staffing shortages.
Microsoft’s recent relationships also point to an increasing focus on developing and deploying generative AI in the pharmaceutical industry. The tech behemoth is partnering with and investing in startups in drug development, where early applications of generative AI have seen especially strong investor and commercial traction.
Using CB Insights data, we uncovered the 4 most important strategic priorities highlighted by Microsoft’s acquisitions, investments, and partnerships in healthcare since 2022. We then categorized companies by their business relationships with Microsoft across these priorities:
- Clinical IT
- Drug development
- Healthcare cloud tools
- Lab & research process improvement
